Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lijun Dai

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Cell Reports|February 22, 2023
Cofilin promotes tau pathology in Alzheimer's diseaseMingmin Yan, Li Tang, Lijun Dai, et al.
Frontiers in Oncology|March 21, 2020
Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?Xiang Li, Na Li, Li Huang, et al.
Aging Cell|November 28, 2022
N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicityLingyan Zhou, Tao Guo, Lanxia Meng, et al.
Immunological Investigations|October 29, 2009
Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II studyStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Immunological Investigations|July 27, 2010
Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II studyStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Leukemia & Lymphoma|June 22, 2022
Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter studyXiang Zhang, Yuqing Tu, Juan Shen, et al.
Circulation Research|July 9, 2005
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptideHimanshu Gupta, Lijun Dai, Geeta Datta, et al.
Chemosphere|September 10, 2022
Exposure to the environmentally toxic pesticide maneb induces Parkinson's disease-like neurotoxicity in mice: A combined proteomic and metabolomic analysisChaoyang Liu, Zehua Liu, Yanyan Fang, et al.
Cell Death and Differentiation|August 22, 2024
The PM20D1-NADA pathway protects against Parkinson's diseaseYunying Yang, Sichun Chen, Li Zhang, et al.
Blood|March 28, 2012
Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation studySuzanne Lentzsch, Amy O'Sullivan, Ryan C Kennedy, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Cell Reports|February 22, 2023
Cofilin promotes tau pathology in Alzheimer's diseaseMingmin Yan, Li Tang, Lijun Dai, et al.
Frontiers in Oncology|March 21, 2020
Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?Xiang Li, Na Li, Li Huang, et al.
Aging Cell|November 28, 2022
N-homocysteinylation of α-synuclein promotes its aggregation and neurotoxicityLingyan Zhou, Tao Guo, Lanxia Meng, et al.
Immunological Investigations|October 29, 2009
Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II studyStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Immunological Investigations|July 27, 2010
Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II studyStephen E Wright, Kathleen A Rewers-Felkins, Imelda S Quinlin, et al.
Leukemia & Lymphoma|June 22, 2022
Effectiveness and safety of leukapheresis in hyperleukocytic leukemias: a retrospective multicenter studyXiang Zhang, Yuqing Tu, Juan Shen, et al.
Circulation Research|July 9, 2005
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptideHimanshu Gupta, Lijun Dai, Geeta Datta, et al.
Chemosphere|September 10, 2022
Exposure to the environmentally toxic pesticide maneb induces Parkinson's disease-like neurotoxicity in mice: A combined proteomic and metabolomic analysisChaoyang Liu, Zehua Liu, Yanyan Fang, et al.
Cell Death and Differentiation|August 22, 2024
The PM20D1-NADA pathway protects against Parkinson's diseaseYunying Yang, Sichun Chen, Li Zhang, et al.
Blood|March 28, 2012
Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation studySuzanne Lentzsch, Amy O'Sullivan, Ryan C Kennedy, et al.
Pageof 8